AU2001260794A1 - Use of egg white and egg white fractions for tissue regeneration - Google Patents

Use of egg white and egg white fractions for tissue regeneration

Info

Publication number
AU2001260794A1
AU2001260794A1 AU2001260794A AU6079401A AU2001260794A1 AU 2001260794 A1 AU2001260794 A1 AU 2001260794A1 AU 2001260794 A AU2001260794 A AU 2001260794A AU 6079401 A AU6079401 A AU 6079401A AU 2001260794 A1 AU2001260794 A1 AU 2001260794A1
Authority
AU
Australia
Prior art keywords
egg white
fractions
tissue regeneration
egg
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260794A
Inventor
Gerrit Jan Beumer
Maria Cornelia Rudolfje Poland
Noortje Martina Augustina Van Beek
Jeroen Johannes Maria Van Den Berg
Gerrit Jan Witte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of AU2001260794A1 publication Critical patent/AU2001260794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
AU2001260794A 2000-05-23 2001-05-23 Use of egg white and egg white fractions for tissue regeneration Abandoned AU2001260794A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57737700A 2000-05-23 2000-05-23
US09577377 2000-05-23
PCT/NL2001/000395 WO2001089540A1 (en) 2000-05-23 2001-05-23 Use of egg white and egg white fractions for tissue regeneration

Publications (1)

Publication Number Publication Date
AU2001260794A1 true AU2001260794A1 (en) 2001-12-03

Family

ID=24308441

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260794A Abandoned AU2001260794A1 (en) 2000-05-23 2001-05-23 Use of egg white and egg white fractions for tissue regeneration

Country Status (2)

Country Link
AU (1) AU2001260794A1 (en)
WO (1) WO2001089540A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007285483B2 (en) * 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
EP2296676B1 (en) 2008-05-09 2016-11-02 Regenics AS Cellular extracts
AU2011249478B2 (en) 2010-05-06 2014-12-04 Regenics As Use of cellular extracts for skin rejuvenation
ITMI20121076A1 (en) * 2012-06-20 2013-12-21 Giellepi S P A COMPOSITION FOR LOCAL USE IN TREATMENT OF TISSUE DAMAGE
EP3459522B1 (en) * 2012-12-10 2021-02-17 Regenics AS Use of egg cellular extracts for wound treatment
WO2020079484A1 (en) * 2018-10-19 2020-04-23 Regenics As Use of egg cellular extract for wound healing
CN116421708B (en) * 2023-03-31 2024-02-09 南京工业大学 Extraction of ovalbumin from pigeon egg white and application of ovalbumin in wound repair

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1037510B (en) * 1975-04-23 1979-11-20 Terapeutica Off AGENT FOR THE THERAPY OF INTESTINAL BACTERIAL INFECTIONS
CA1221046A (en) * 1984-05-30 1987-04-28 Lorne S. Reid Method for separating lysozyme from egg-white
CH675686A5 (en) * 1986-06-13 1990-10-31 Japan Immuno Res Lab
NL1003748C2 (en) * 1996-08-06 1998-02-12 Nutricia Nv Drinkable, acidic food preparation with a long shelf life and health-promoting effect.
JPH10251141A (en) * 1997-03-05 1998-09-22 Masao Nakayama Immovable preparation having special efficacy for external use for burned skin

Also Published As

Publication number Publication date
WO2001089540A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001270943A1 (en) Surgical instrument and method of using the same
AU2001277038A1 (en) Methods and instruments for improving refractive ophthalmic surgery
AU2001249967A1 (en) Composition and methods for tissue preservation
AU2002225912A1 (en) Tissue removal using biocompatible materials
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
AU6222800A (en) Surgical illumination device and method of use
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2002221277A1 (en) Internal fixator of bones
AUPQ679100A0 (en) Process and composition for cleaning medical instruments
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
AU2002246849A1 (en) Agents and methods for promoting bone growth
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001260794A1 (en) Use of egg white and egg white fractions for tissue regeneration
AU2002216092A1 (en) Method and device for determining the topology of biological tissue
AU2591299A (en) Human protein kinase c inhibitor
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001268236A1 (en) Use of aicar and related compounds
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AUPR069500A0 (en) Tissue modification
AU3863900A (en) Prolyl peptidases and methods of use